CXCL8 and cancer: It has been reported to promote angiogenesis and cancer growth (Wang et al., 2015), therefore in previous experiments, we tried to abolish the chemoresistance acquisition by OTCs using an antibody directed against IL-8 (Skov et al., 2008).